CARULLI, Lucia
 Distribuzione geografica
Continente #
NA - Nord America 10.152
EU - Europa 4.003
AS - Asia 1.900
SA - Sud America 43
AF - Africa 13
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 16.127
Nazione #
US - Stati Uniti d'America 10.120
GB - Regno Unito 1.257
IT - Italia 780
SG - Singapore 609
CN - Cina 593
SE - Svezia 478
DE - Germania 472
UA - Ucraina 313
HK - Hong Kong 274
TR - Turchia 216
FI - Finlandia 179
RU - Federazione Russa 146
FR - Francia 111
BG - Bulgaria 110
IN - India 43
ID - Indonesia 36
BE - Belgio 29
CA - Canada 27
BR - Brasile 24
IE - Irlanda 22
JP - Giappone 17
IR - Iran 16
NL - Olanda 16
BD - Bangladesh 14
CZ - Repubblica Ceca 14
TW - Taiwan 14
ES - Italia 13
CH - Svizzera 12
VN - Vietnam 12
MY - Malesia 10
CL - Cile 9
KR - Corea 9
IQ - Iraq 8
LT - Lituania 8
NO - Norvegia 8
AU - Australia 7
PL - Polonia 7
RO - Romania 6
ET - Etiopia 5
EU - Europa 5
MX - Messico 5
PH - Filippine 5
SI - Slovenia 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
AT - Austria 3
EC - Ecuador 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
PK - Pakistan 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CO - Colombia 2
DK - Danimarca 2
HR - Croazia 2
IL - Israele 2
KW - Kuwait 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TJ - Tagikistan 2
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
EG - Egitto 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 16.127
Città #
Fairfield 1.379
Santa Clara 1.195
Southend 978
Woodbridge 759
Ashburn 720
Houston 716
Chandler 697
Jacksonville 542
Cambridge 463
Seattle 462
Wilmington 423
Dearborn 416
Ann Arbor 408
Singapore 402
Nyköping 319
Hong Kong 269
Modena 223
Beijing 168
San Diego 154
Izmir 134
Princeton 121
Sofia 110
Eugene 101
Helsinki 91
New York 84
Fremont 54
Shanghai 47
Des Moines 46
London 43
Redwood City 38
Munich 37
Jakarta 36
Moscow 35
Bologna 34
Milan 34
Boardman 30
Brussels 27
Falls Church 26
Bremen 25
Hefei 22
Rome 22
San Mateo 22
Dongguan 18
Kunming 18
Hounslow 17
Norwalk 17
Toronto 17
Frankfurt am Main 16
Guangzhou 16
Parma 16
Dublin 15
Kilburn 14
Phoenix 14
Brno 13
Grafing 12
Chiswick 11
Nanjing 11
Bari 10
Nanchang 10
Dong Ket 9
Taipei 9
Chicago 8
Dallas 8
Dhaka 8
Kocaeli 8
Livorno 8
Rio Saliceto 8
Baotou 7
Indiana 7
Leawood 7
Los Angeles 7
Ottawa 7
Reggio Emilia 7
Shenyang 7
Verona 7
Formia 6
Fuzhou 6
Istanbul 6
Prescot 6
Rho 6
San Francisco 6
Baghdad 5
Catania 5
Harbin 5
Jinan 5
Madrid 5
Monmouth Junction 5
Mountain View 5
Naples 5
Nishinotoindori 5
Saint Petersburg 5
São Paulo 5
Tokyo 5
Washington 5
Albignasego 4
Auburn Hills 4
Augusta 4
Belvedere Spinello 4
Berlin 4
Carpi 4
Totale 12.404
Nome #
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 305
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 291
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 282
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 261
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 243
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 238
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 236
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 234
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 231
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 229
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 227
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 218
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 217
Telomere length elongation after weight loss intervention in obese adults 217
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 211
Gender, fatty liver and GGT 208
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 208
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 204
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 201
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 199
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 197
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 196
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 193
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 193
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 192
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 191
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 188
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 187
Review article: diabetes, genetics and ethnicity 183
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 181
Telomere and telomerase in chronic liver disease and hepatocarcinoma 180
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 176
Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. 176
Endocrine and liver interaction: the role of endocrine pathways in NASH 175
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 173
Review article: effect of bile salt pool composition on hepatic and biliary functions 172
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 171
Telomere shortening as genetic risk factor of liver cirrhosis 169
Hepatic steatosis and insulin resistance: Does etiology make a difference? 162
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 162
The Individual Care Plan (ICP): proposal of a model to improve the communication between hospital and primary health care services 160
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 157
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 156
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 154
Reply 154
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 153
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 150
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 149
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 148
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 148
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 146
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 142
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 141
Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorption 139
Regolazione della sintesi di colesterolo e acidi biliari 138
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 137
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 136
Telomeres and atherosclerosis 135
Olanzapine metabolic side effects: a weight gain issue? 131
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 131
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 129
Antiretroviral drugs induced metabolic diseases in HIV infected patients. 128
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 127
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 126
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 125
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 125
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 125
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 124
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 123
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 121
Genetic polymorphisms in subjects with Non Alcoholic Fatty Liver Disease. 120
Bleeding jejunal varices and portal thrombosis in a splenectomized patient with hereditary spherocytosis 118
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 117
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 117
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 116
Epidemiologia e storia naturale dell'epatopatia steatosica non alcolica 115
Increase degradation of cholesterol via the alternate pathway of bile acid biosynthesis in primary hypercholesterolemia. 113
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 113
The genetic basis of Insulin resistance. A brief review 112
Cirrosi criptogenetiche. Un report di 5 pazienti 111
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 110
Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomeres involvement on line pubblication 03-Oct-2012Hepatology- 107
DIABETES AND CARDIOVASCULAR EVENTS: USEFULNESS AND LIMITS OF RISK FUNCTIONS 101
Risk for cardiovascular events in a local population of diabetic patients 101
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 100
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 96
non alcoholic fatty liver disease ( NAFLD) :is femlae sex safer? 96
Invecchiamento ed alterazioni dell’omeostasi del colesterolo: studi dei livelli plasmatici degli steroli idrossilati come markers metabolici. 95
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 94
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 93
Epatopatia steatosica non alcolica:definizione e aspetti clinici. 93
Fatty liver, carotid disease and gallstones: A study ofage-related associations 92
Cholestatic icterus: is there still a role for the clinic? 92
Sindromi steatosiche non alcoliche. Stato dell'arte e progressi nella ricerca. 90
Olanzapine-induced hypertriglyceridemia and Diabetes mellitus 90
La calcolosi biliare. 89
The OMICs window into nonalcoholic fatty liver disease (NAFLD) 89
Fatty liver disease associated with epatiti C and/or human immunodeficiency virus: characterization of the link between hepatic steatosis, insulin resistance and metabolic syndrome. 88
Gender differences in chronic alcoholic and viral liver diseases 88
Does fatty liver associate with carotid atherosclerosis? 87
Totale 15.478
Categoria #
all - tutte 77.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.550 0 0 0 0 0 0 552 323 278 124 173 100
2020/20212.596 244 88 201 369 360 142 229 268 123 290 183 99
2021/20222.398 108 303 160 203 64 115 182 147 282 133 421 280
2022/20231.970 220 203 170 197 211 312 42 173 248 15 78 101
2023/20241.332 55 71 86 91 253 134 209 165 26 31 65 146
2024/20252.241 120 56 87 322 944 705 7 0 0 0 0 0
Totale 16.310